Patricia D'Amore
Editor-in-Chief, Vascular Biology · 2026–present
Massachusetts Eye and Ear Infirmary
Dr. D’Amore earned her PhD in Biology from Boston University, was a postdoctoral fellow in at Johns Hopkins Medical School, then moved to Boston Children’s Hospital as Assistant Professor. She earned an MBA in Finance from Northeastern University. In 1998, she became Charles L. Schepens Professor of Ophthalmology and Professor of Pathology at Harvard Medical School (HMS). She is the Associate Chief of Basic and Translational Research for Ophthalmology at Mass. Eye and Ear (MEE) and the Vice Chair of Basic and Translational Research for the Department of Ophthalmology. Dr. D’Amore is an international expert in vascular growth and development and has been at the forefront of angiogenesis research for over four decades. In collaboration with colleagues from HMS and MEE, she contributed to the scientific foundation for anti-VEGF therapies for which they received the 2015 António Champalimaud Award. In addition, she has revealed important physiological roles of VEGF. Her laboratory also developed a widely used mouse model of oxygen-induced retinopathy. Her current interests are two-fold: (i) the endothelial glycocalyx in the regulation of endothelial-leukocyte interactions and angiogenesis and (ii) toxic effect of lipids on the retinal pigment epithelium in the pathogenesis of AMD. Dr. D’Amore has published more than 190 peer-reviewed papers and 75 reviews. She is the recipient of the Alcon Research Award, Cogan Award from the Association for Research in Vision and Ophthalmology (ARVO), the Rous-Whipple Award from the Society of Investigative Pathology, the Endre A. Balazs Award from the International Society for Eye Research, the Proctor Medal from ARVO, the Roger Johnson Award in Macular Degeneration Research from the University of Washington, Seattle, and the Research to Prevent Blindness David F. Weeks Award. She was elected to the American Academy of Arts and Sciences in 2018.
- Biological sciences